Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic
- PMID: 33913911
- PMCID: PMC8186619
- DOI: 10.4103/ijo.IJO_3504_20
Lockdown effects on a patient receiving immunosuppression for unilateral HLA- B27 associated uveitis during COVID-19 pandemic
Conflict of interest statement
None
Comment on
-
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.Br J Ophthalmol. 2021 Mar;105(3):306-310. doi: 10.1136/bjophthalmol-2020-316586. Epub 2020 Jun 12. Br J Ophthalmol. 2021. PMID: 32532764 Free PMC article. Review.
References
-
- Zierhut M, De Smet MD, Gupta V, Pavesio C, Nguyen QD, Chee S-P, et al. Evolving consensus experience of the IUSG-IOIS-FOIS with uveitis in the time of COVID-19 infection. Ocul Immunol Inflamm. 2020;3(28):709–13. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources